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Research
Polychlorinated biphenyls (PCBs) and methyl-
mercury (MeHg) have long been recognized as 
neurotoxicants that present a potential threat 
to public health. Humans are exposed primar-
ily via consumption of contaminated fish and 
seafood. The fetus and neonate are particularly 
vulnerable to these contaminants because of 
exposure during critical periods of nervous sys-
tem development. PCBs and MeHg are read-
ily transferred to the fetus during gestation, 
and PCBs are also transferred to the neonate 
through lactation (Rogan et al. 1986a, 1986b). 
Studies of human populations have identified 
various adverse outcomes after developmental 
exposure to PCBs and MeHg, including cog-
nitive, motor, and sensory deficits (Wigle et al. 
2008). Numerous studies using animal models 
have further detailed the nervous system effects 
of early exposure (Ulbrich and Stahlmann 
2004; Watanabe and Satoh 1996).
Studies of auditory function in PCB- or 
MeHg-exposed humans are limited, but they 
do suggest that low-level prenatal exposure 
may impair hearing. Abnormalities of audi-
tory-evoked potentials have been observed in 
children with early exposure to PCBs, indi-
cating that exposure alters auditory processing 
in the central nervous system (Chen and Hsu 
1994; Vreugdenhil et al. 2004). A study of a 
PCB-exposed population in the Faroe Islands 
measured hearing thresholds using traditional 
audiometric methods at 7 years and found 
increased thresholds at 250 Hz and 12,000 Hz 
that were associated with higher prenatal PCB 
exposure, but only in the left ear (Grandjean 
et al. 2001). Longnecker et al. (2004) observed 
a slight increase in hearing threshold at 2,000 
Hz in the left ear and 4,000 Hz in the right 
ear but concluded there was no clinically sig-
nificant risk of hearing loss associated with pre-
natal PCB exposure. Similar auditory deficits 
have been associated with early MeHg exposure 
(Murata et al. 1999, 2004), but they observed 
deficits only in one ear and/or only at specific 
frequencies, perhaps decreasing confidence in 
the findings.
Laboratory animal models have provided 
stronger evidence for PCB- and MeHg-
induced auditory deficits. Developmental expo-
sure to the commercial PCB mixture Aroclor 
1254 has been demonstrated to result in per-
manent low-frequency hearing impairment 
(Goldey et al. 1995; Herr et al. 1996). Further 
studies indicated that PCB-induced reductions 
of thyroid hormone concentrations were at 
least partially responsible for the hearing loss 
(Goldey and Crofton 1998). The cochlea has 
been implicated as the likely site of action for 
the PCB-induced hearing loss. Rats develop-
mentally exposed to Aroclor 1254 exhibited 
a loss of outer hair cells on the organ of Corti 
(Crofton et al. 2000). Another study mea-
sured distortion product otoacoustic emissions 
(DPOAEs), which assess the functional integ-
rity of the outer hair cells of the cochlea, and 
found impairments in rats perinatally exposed 
to Aroclor 1254 (Lasky et al. 2002). Although 
these hearing impairments in Aroclor 1254–
exposed rats were limited to low frequencies, 
our previous work has demonstrated hearing 
impairments across a wide range of frequen-
cies in rats exposed perinatally to an environ-
mental mixture of PCBs (Powers et al. 2006). 
Exposed rats had attenuated DPOAEs, as well 
as elevated DPOAE and auditory brainstem 
response (ABR) thresholds. More recently, 
Kenet et al. (2007) reported that exposure to 
PCB-95, a specific ortho-substituted PCB con-
gener, disrupted the development of the audi-
tory cortex in rats. This included an altered 
tonotopic organization of the A1 field and 
reduced receptive field selectivity of individual 
neurons in A1. However, ABR thresholds were 
reported to be unaffected in these rats.
Laboratory animal studies of the effects 
of MeHg exposure on auditory function also 
report hearing loss. Rice and Gilbert (1992) 
examined monkeys exposed to MeHg from 
birth to 7 years of age and observed eleva-
tions in pure tone detection thresholds in the 
mid- to high-frequency range. An extension 
of this research examined monkeys exposed to 
MeHg throughout gestation and continuing 
postnatally until 4 years of age (Rice 1998). 
Pure tone detection thresholds were elevated 
in MeHg-exposed monkeys, and the deficits 
extended over an even wider range of fre-
quencies. Two studies using a mouse model 
have reported elevated ABR thresholds after 
chronic, low-dose exposure to MeHg (Chuu 
et al. 2001; Huang et al. 2008).
In the present study, we extended our pre-
vious research on PCBs alone to investigate 
coexposure to PCBs and MeHg. Scientific 
evidence that PCB and MeHg exposure may 
have interactive effects is building. The effects 
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of coexposure were investigated in the Oswego 
Newborn and Infant Development Project, 
a prospective birth cohort study that assessed 
the relationship between prenatal contami-
nant exposure and neuropsychological func-
tion during childhood. Although the study 
did not definitively identify additive or syn-
ergistic neurotoxic effects, a statistical interac-
tion between PCB and MeHg exposure was 
observed, with an association between MeHg 
exposure and neurobehavioral end points that 
was stronger in children who had higher PCB 
exposure (Stewart et al. 2003).
Further evidence for interactive effects of 
PCBs and MeHg has been gained from in vitro 
studies. Bemis and Seegal (1999) reported that 
rat brain (striatum) tissues exposed to PCBs 
alone show a concentration-dependent reduc-
tion in dopamine content. Exposure to MeHg 
alone had no significant effect on dopamine 
(with the exception of the highest concentra-
tion tested). However, exposure to mixtures 
of PCBs and MeHg resulted in greater reduc-
tions in dopamine levels than did exposure to 
PCBs alone, suggesting an interaction between 
the two compounds. Continuing this line of 
research, Bemis and Seegal (2000) reported 
an interactive effect of PCBs and MeHg on 
intracellular calcium concentrations in rat cer-
ebellar granule cells. Exposure to either PCBs 
or MeHg resulted in concentration-dependent 
calcium elevations. Low-combination doses 
also elevated calcium concentrations, but there 
was a statistical interaction identifying a differ-
ence between the effects of combined exposure 
and exposure to either PCBs or MeHg indi-
vidually, with combined exposure resulting 
in greater elevations. Furthermore, high-com-
bination doses or longer exposure durations 
to low-combination doses reduced calcium 
concentrations compared with the elevations 
observed after exposure to MeHg only. These 
studies provide evidence that PCBs and MeHg 
may have interactive effects that depend on the 
concentration and timing of the exposure.
The effects of combined exposure to PCBs 
and MeHg have also been studied in vivo in 
rodents. Roegge et al. (2004) investigated motor 
function in rats after developmental exposure to 
PCBs alone, MeHg alone, or PCBs and MeHg. 
They tested rats on cerebellar tasks, including 
traversing a rotating rod. Rats exposed to PCBs 
alone were slightly impaired on the rotating 
rod task, whereas rats exposed to MeHg alone 
did not differ from controls. However, com-
bined exposure to PCBs and MeHg resulted 
in a substantial impairment relative to controls, 
suggesting an additive or interactive effect of 
the two contaminants. Littermates of those 
rats were examined on a working memory 
task using operant testing chambers (Widholm 
et al. 2004). PCB-only and MeHg-only groups 
showed performance deficits. The combined 
exposure group showed similar deficits, but the 
magnitude of the effect was no different from 
the effects of individual contaminant exposure. 
Using a mouse model, Fischer et al. (2008) 
report altered spontaneous behavior after expo-
sure to PCB-153, and coexposure to MeHg 
exacerbated the behavioral deficit.
In the present study, we used the rat as a 
model to study combined exposure to PCBs 
and MeHg. We formulated a unique PCB 
mixture to match the PCB congener pro-
file in fish from the Fox River in northeast 
Wisconsin (Kostyniak et al. 2005). MeHg 
doses were selected to achieve a ratio of PCBs 
to MeHg similar to that found in the fish. 
Thus, the study modeled exposures in a paral-
lel study of consumers of sport-caught fish in 
northeast Wisconsin. The goal of this study 
was to determine if developmental exposure 
to these contaminants results in long-term 
effects on auditory function.
Materials and Methods
Animals. Primiparous female Long-Evans 
rats, approximately 60 days of age, were pur-
chased in three cohorts spaced approximately 
6 months apart, from Harlan (Madison, WI). 
We maintained animals used in these studies 
in facilities accredited by the Association for the 
Assessment and Accreditation of Laboratory 
Animal Care. Specifically, rats were individu-
ally housed in standard plastic shoebox cages 
with corn-cob bedding, in a temperature- and 
humidity-controlled room (22°C, 40–55% 
humidity) on a 12/12-hr reverse light/dark 
cycle (lights off at 0830 hr). Food and water 
were available ad libitum. Rats were fed Harlan 
Teklad rodent diet (W) 8604. All procedures 
were approved by the Institutional Animal Care 
and Use Committee at the University of Illinois 
at Urbana-Champaign and were in accordance 
with the guidelines of the National Institutes of 
Health (2002) and National Research Council 
(2003). We treated the rats humanely and with 
regard for alleviation of suffering.
Exposure. After 2 weeks of adaptation 
to the vivarium, the rats in each cohort were 
assigned to exposure groups (distributed evenly 
by body weight) and given one of seven treat-
ments consisting of PCBs and/or MeHg, or 
control treatment (see Table 1). Exposure 
began 28 days before breeding and contin-
ued until pups were weaned on postnatal day 
(PND) 21. We formulated the PCB mixture 
to mimic the congener profile found in wall-
eye, a popular sport-caught fish, taken from the 
Fox River in northeast Wisconsin. The mixture 
consisted of 35% Aroclor 1242 (Monsanto lot 
KB 05-415; St. Louis, MO) 35% Aroclor 1248 
(AccuStandards lot F-110; New Haven, CT), 
15% Aroclor 1254 (Monsanto lot KB 05-612), 
and 15% Aroclor 1260 (AccuStandards lot 
021-020). We found the mixture had rela-
tively low aryl hydrocarbon receptor activity 
but high ryanodine receptor (RyR) activity (see 
Kostyniak et al. 2005). The doses of the PCB 
mixture (1 and 3 mg/kg) were selected based 
on the results of earlier studies assessing the 
in vivo developmental toxicity and auditory tox-
icity of the mixture in rats (see Kostyniak et al. 
2005; Powers et al. 2006). The PCB mixture 
was diluted in corn oil (Mazola) and pipetted 
onto one-half of a vanilla wafer cookie (Keebler 
Golden Vanilla Wafers) at a volume of 0.4 
mL/kg. To arrive at a dose of 0.4 mL/kg, the 
dosing solutions were mixed at concentrations 
of 2.5 mg/mL and 7.5 mg/mL for the PCB 
doses of 1 mg/kg and 3 mg/kg, respectively. 
The PCB-dosed cookies were fed to the female 
rats daily at approximately 1100 hr. Doses were 
adjusted daily to account for weight gain. Corn 
oil vehicle alone was pipetted onto cookies for 
rats in treatment groups that did not receive 
PCBs. Methylmercury was administered in the 
drinking water at concentrations of 1.5 and 
4.5 ppm when rats were in their home cages. 
Adulterated water dosed with MeHg was put 
into plastic water bottles fitted with screw tops 
and ball tips to prevent spillage. Unadulterated 
drinking water was given to rats in treatment 
groups that did not receive MeHg and to all 
male rats used for breeding. We selected these 
doses of MeHg to yield a ratio of PCBs to 
MeHg similar to that measured in walleye from 
the Fox River, which was approximately 6:1 
(Wisconsin Department of Natural Resources, 
unpublished data). The average daily amount 
of MeHg consumed across the entire dos-
ing period was measured for dams in the first 
cohort only, which resulted in a ratio of PCBs 
to MeHg that was approximately 4.4:1 and 
4.9:1 in the low and high combined exposure 
groups, respectively (see Table 1).
Breeding, pregnancy, and weaning. Four 
weeks after the initiation of exposure, we paired 
each female with an unexposed male Long-
Evans rat (Harlan, Madison, WI) in a hanging 
wire cage for 8 consecutive days. The breeding 
cages contained standard rat chow and stan-
dard tap water (ad libitum) to ensure that the 
males did not receive any MeHg exposure. The 
females were returned to their home cages each 
day for PCB dosing, where access to MeHg 
water was also available to MeHg exposure 
groups. We confirmed consumption of the 
Table 1. Number of litters per treatment group and 
MeHg intake.
    MeHg intake
Treatment group  No.  (µg/kg)a
Control  9  N/A
1 mg/kg PCB  7  N/A
3 mg/kg PCB  7  N/A
1.5 ppm MeHg  7  209.6 ± 18.4
4.5 ppm MeHg  7  715.7 ± 58.2
1 mg/kg PCB + 1.5 ppm MeHg  9  228.8 ± 22.0
3 mg/kg PCB + 4.5 ppm MeHg  9  611.9 ± 55.1
aMeHg dissolved in drinking water reported as average 
daily intake (mean ± SE) for the entire dosing period for 
cohort 1.Contaminant exposure and auditory function
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cookie before we returned the females to the 
breeding cages. The females were monitored 
twice daily for the presence of a sperm plug in 
order to establish gestational day 0. Females 
that did not give birth were retained and their 
uteri examined for implantation sites.
On the day of parturition (PND 0), we 
examined the pups for gross abnormalities, 
sexed and weighed them, and noted the num-
ber of stillbirths. On PND 2, the litters were 
culled to 10 pups (five males and five females 
when possible), and small litters were cross-
fostered with extra pups from the same treat-
ment group when possible to bring them to 
8–10 pups. Cross-fostered pups were marked 
by ear clip and were not used for auditory 
testing. Thereafter, pups were weighed weekly 
until approximately PND 70.
Because of concern about the pups being 
able to reach the water bottle, MeHg dosing 
of the dams stopped on PND 16. PCB dos-
ing continued until the pups were weaned on 
PND 21. On PND 21, we euthanized the dam 
from each litter and recorded the liver weight 
and number of uterine implantation sites. Four 
pups per litter were retained, one male and 
one female for auditory testing for the pres-
ent results, and one male and one female for 
cognitive testing (data reported elsewhere), 
and euthanized the remaining pups. Of these 
remaining pups, we obtained organ weights 
(brain, liver, and thymus) from one male and 
female per litter. We housed pups retained on 
the day of weaning in same-exposure, same-sex 
pairs or triplets with food and water ad libitum. 
Auditory testing began at approximately PND 
200 to determine if developmental exposures 
resulted in permanent hearing deficits.
Distortion product otoacoustic emissions. 
DPOAEs are acoustic responses generated when 
the cochlea is stimulated by two pure tones 
(called f1 and f2 primaries). The DPOAEs at 
the frequency 2f1 – f2 are commonly measured 
experimentally to assess outer hair cell function. 
Loss of outer hair cells or impairment of outer 
hair cell function results in the attenuation of 
DPOAE amplitudes. We conducted DPOAE 
testing in a sound-attenuated chamber, lined 
with sound-absorbing foam, within an isolated 
laboratory. Before testing, rats were sedated with 
0.5 mL/kg ketamine/xylazine (87:13) intraperi-
toneally. Once sedated, rats were placed on a 
thermo-regulating heating pad (no. 50-7053-R, 
Harvard Apparatus, Holliston, MA) to main-
tain body temperature. Rats were placed on 
their sides and the probe was positioned in the 
left ear canal.
We recorded the DPOAEs using Tucker 
Davis Technologies (TDT; Alachua, FL) 
System 2/System 3 digital signal processing 
hardware and software. Stimuli were directed 
into the ear canal through a single ear probe. 
The probe contained two earphones and 
a microphone and had a soft rubber tip that 
sealed the ear canal from external noise. We 
created all DPOAE stimuli using TDT SigGen 
software and conducted recordings using TDT 
BioSig software. Details regarding the instru-
mentation can be found in Powers et al. (2006).
The DPOAEs were generated by simul-
taneously presenting two sinusoids, f1 and f2 
(f2/f1 = 1.2), into the sealed ear canal of the 
rat. We calibrated the sound levels for the f1 
and f2 primaries to 60 dB sound pressure level 
(SPL) and 50 dB SPL (0 dB = 20 µPa), respec-
tively, using a pressure field microphone (no. 
4192, Bruel and Kjaer, Norcross, GA) in a 
2-cc calibration coupler (no. 4946, Bruel and 
Kjaer). The amplitude of the distortion prod-
uct at the frequency defined by 2f1 – f2 was 
then measured by recording the pressure in 
the sealed ear canal. In mammals, the 2f1 – f2 
distortion product is the most robust and is 
commonly measured as a reliable indicator of 
outer hair cell function (Lonsbury-Martin and 
Martin 1990). We selected six stimulus pairs 
for DPOAE testing, which included f2 = 2, 3, 
4, 6, 8, and 12 kHz.
DPOAE testing consisted of measuring 
suprathreshold DPOAE amplitudes followed 
by DPOAE thresholds at each of the six stimu-
lus pairs, beginning with 2 kHz. Each distor-
tion product was the average response of 100 
stimulus pair presentations (presentation rate 
= 6/sec). We repeated this so that the final dis-
tortion product represented an average of the 
two trials (each having 100 separate stimulus 
presentations). DPOAE amplitudes were cal-
culated by subtracting surrounding noise from 
the 2f1 – f2 distortion product. The noise was 
defined as the average of the 10 neighboring 
frequencies (five above and five below the 2f1 – 
f2 distortion product). After the suprathreshold 
amplitudes were measured, DPOAE thresholds 
were then determined by reducing the f1 and 
f2 primaries in 5-dB steps. We defined thresh-
olds as the lowest f2 dB level at which the 2f1 
– f2 distortion product was > 6 dB above the 
surrounding noise.
Auditory brainstem responses. The ABR is 
a far-field electrical recording of neural acti-
vity associated with the processing of acous-
tic information. We conducted testing in 
the same chamber and prepared rats for the 
procedure as they were for DPOAE testing. 
ABRs were recorded using the same TDT 
hardware. Stimuli were directed through 
a 10-cm tube, fitted with a rubber tip that 
allowed for the tones to be presented into 
the sealed ear canal. We recorded the ABR 
responses using needle electrodes (FE-2, Grass 
Technologies, West Warwick, RI) connected 
to a headstage (TDT no. HS-4) and a bioamp 
controller (TDT no. DB-4) that amplified the 
analog voltage recordings 60,000 times and 
band-pass filtered them with 3-dB cutoffs at 
100 Hz and 3 kHz before being digitally con-
verted (TDT no. AD-1). The sampling rates 
to generate stimuli and digitize the responses 
were 125 kHz and 20 kHz, respectively.
The ABR stimulus was a 65-dB SPL sinu-
soid presented at a rate of 21.8/sec, with 1/3 
rise, 1/3 plateau, and 1/3 fall times. The fre-
quencies selected for testing included 1.5, 3, 
6, 12, and 24 kHz, and we presented them 
sequentially beginning with the lowest fre-
quency. The stimulus energy was equated for 
the two lowest frequencies by setting the dura-
tion to 3 msec for the 1.5 kHz stimuli and 
1.5 msec for the 3 kHz stimuli (i.e., 4.5 cycles 
per stimulus presentation), but technical limi-
tations prevented matching with the higher 
frequency stimuli. The ABR waveforms were 
produced via differential voltage recordings 
from needle electrodes placed under the skin on 
the scalp at the vertex (noninverting electrode) 
and ipsilateral mastoid (inverting electrode). 
The ground electrode was placed on the back of 
the neck. Each ABR waveform represented the 
average response to 500 stimulus presentations, 
and we determined the final analyzable ABR 
waveform by averaging the waveforms from two 
consecutive ABR trials (each the product of 500 
stimulus presentations). Figure 1 shows a repre-
sentative ABR waveform, indicating peaks 1–4. 
We measured latency and amplitude (peak to 
following trough) of each of the first four posi-
tive peaks of the response to the suprathreshold 
stimuli. ABR thresholds were then determined 
by reducing the stimulus level in 5-dB steps and 
were defined as the lowest decibel level at which 
peak 2 could be positively identified.
Statistical analysis. We conducted all sta-
tistical analyses using SPSS for MS Windows 
(version 15.0; SPSS Inc., Chicago, IL) 
with statistical significance set at p < 0.05. 
DPOAE amplitudes, DPOAE thresholds, 
ABR thresholds, and ABR peak amplitudes 
and peak latencies were analyzed via separate 
three-way analyses of variance with exposure 
as a between-subjects variable, frequency as 
a repeated measure, litter as the unit of vari-
ance, and sex nested within litter. ABR wave-
forms generated by the 1.5-kHz stimuli were 
Figure 1. An ABR waveform generated from a 
control rat in response to a 6-kHz tone at 65 dB, 
indicating peaks 1–4. 
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irregular in appearance, in that peak 2 was 
identifiable whereas peaks 1, 3, and 4 were 
not. Therefore, we used the 1.5-kHz data in 
the analysis of ABR thresholds, but not ABR 
amplitudes and latencies. We conducted post 
hoc comparisons, using Tukey’s test, to exam-
ine the nature of significant treatment effects 
obtained from the overall analyses.
Results
Reproductive and developmental outcomes. We 
saw no overt signs of clinical toxicity in the 
dams from any treatment group. There were 
no significant treatment effects related to litter 
size, percent males, percent live births per litter, 
or implantation sites. We observed no effect of 
treatment on timing of eye opening in pups. At 
PND 21, ratios of liver to body weight were sig-
nificantly increased in groups exposed to PCBs, 
regardless of whether the dams were also treated 
with MeHg. This reflects liver enzyme induc-
tion in PCB-exposed pups. Ratios of brain to 
body weight were not affected by treatment. 
Ratios of thymus to body weight were signifi-
cantly decreased in female pups in the 3 mg/kg 
PCB group, the low PCB + MeHg group, and 
the high PCB + MeHg group. We observed no 
effect of treatment on birth weight or postnatal 
weight gain in pups, with the exception of a 
slight increase at weaning (PND 21) in the 1.5 
ppm MeHg group and the 1 mg/kg PCB + 1.5 
ppm MeHg group. Further details pertaining to 
the reproductive and developmental outcomes 
are reported in Sable et al. (2009).
DPOAEs. Figure 2 illustrates DPOAE 
amplitudes at 2, 3, 4, 6, 8, and 12 kHz for 
control and PCB- and/or MeHg-exposed rats. 
The DPOAE amplitudes of rats exposed only 
to PCBs were attenuated at all frequencies. 
This was reflected in a significant main effect 
of exposure [F (6, 48) = 4.216; p = 0.002]. We 
also found a significant effect of frequency [(5, 
240) = 50.696; p < 0.001] and a sex × frequency 
interaction [F (5, 240) = 4.349; p = 0.001]. A 
comparison of the sexes revealed that DPOAE 
Figure 2. Group mean DPOAE amplitudes of control rats compared with exposed rats. Exposure to PCBs only (A), MeHg only (B), or PCBs + MeHg (C). 
*Main effect across all frequencies is significantly different from controls (p < 0.05).
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amplitudes of male rats were greater at 2 kHz 
and lower at 12 kHz (data not shown). There 
was not a significant effect of sex or any signifi-
cant exposure interactions. Tukey’s test revealed 
that DPOAE amplitudes of the 3 mg/kg PCB 
group were significantly lower than those of the 
control group (p = 0.016), the 1.5 ppm MeHg 
group (p = 0.029), and the 4.5 ppm MeHg 
group (p = 0.002). None of the MeHg groups 
or PCB + MeHg groups differed from controls.
Figure 3 illustrates DPOAE thresholds at 
2, 3, 4, 6, 8, and 12 kHz for control and PCB- 
and/or MeHg-exposed rats. DPOAE thresh-
olds for PCB-only and PCB + MeHg rats were 
elevated compared with control rats. This was 
reflected in a significant effect of exposure 
[F (6, 48) = 6.615; p < 0.001]. We also found 
a significant effect of frequency [F (5, 240) 
= 142.352; p < 0.001], as well as a frequency 
× exposure interaction [F (30, 240) = 2.114; 
p = 0.001] and a frequency × sex × exposure 
interaction [F (30, 240) = 60.046; p = 0.012] 
on DPOAE thresholds. No significant effects 
of sex or of sex × exposure or of sex × frequency 
interactions were observed on DPOAE thresh-
olds. In male rats, DPOAE thresholds at 2 kHz 
were elevated compared with controls in the 
1 mg/kg PCB group (p = 0.025), the 3 mg/kg 
PCB group (p = 0.007), and the 3 mg/kg PCB 
+ 4.5 ppm MeHg group (p =0.006); thresholds 
at 3 kHz were also elevated compared with con-
trols in the 1 mg/kg PCB group (p = 0.003), 
the 3 mg/kg PCB group (p = 0.037), and 
the 3 mg/kg PCB + 4.5 ppm MeHg group 
(p = 0.005). We found no significant differ-
ences at 4, 6, 8, or 12 kHz in male rats. In 
female rats, DPOAE thresholds at 2 kHz were 
elevated compared with controls in the 1 mg/
kg PCB group (p = 0.009), the 3 mg/kg PCB 
group (p = 0.001), and the 3 mg/kg PCB + 
4.5 ppm MeHg group (p = 0.009); thresholds 
at 3 kHz were elevated compared with controls 
only in the 3 mg/kg PCB group (p = 0.006), 
and the 3 mg/kg PCB group also had elevated 
thresholds compared with controls at 4 kHz 
(p = 0.010) and 12 kHz (p = 0.008).
ABRs. Figure 4 illustrates ABR thresholds 
at 1.5, 3, 6, 12, and 24 kHz for control and 
PCB- and/or MeHg-exposed rats. ABR thresh-
olds for PCB-only and PCB + MeHg rats were 
elevated compared with control rats. This was 
reflected in a significant effect of exposure 
[F (6, 48) = 3.209; p < 0.010]. We also found 
a significant effect of frequency [F (4, 192) = 
333.027; p < 0.001] and a significant effect of 
sex [F (1, 48) = 8.983; p = 0.004], as well as a 
frequency × exposure interaction [F (24, 192) 
= 2.375; p = 0.001]. The effect of sex resulted 
from the females having lower ABR thresh-
olds compared with the males. There were no 
observed sex × exposure or sex × frequency 
interactions. At 1.5 kHz, ABR thresholds were 
significantly elevated compared with control 
rats in the 1 mg/kg PCB group (p = 0.004), the 
3 mg/kg PCB group (p < 0.001), the 4.5 ppm 
MeHg group (p = 0.050), the 1 mg/kg PCB 
+ 1.5 ppm MeHg group (p = 0.007), and 
the 3 mg/kg PCB + 4.5 ppm MeHg group 
(p = 0.012). At 3 kHz, ABR thresholds were sig-
nificantly elevated compared with control rats 
only in the 3 mg/kg PCB group (p = 0.007). 
At 6 kHz, we found no significant differences 
in ABR thresholds. At 12 kHz, ABR thresholds 
were significantly elevated compared with con-
trol rats in the 1 mg/kg PCB group (p = 0.048) 
and the 3 mg/kg PCB group (p = 0.028). At 
24 kHz, there were no significant differences in 
ABR thresholds.
Figure 5 illustrates ABR peak 1 amplitude 
across all frequencies for each experimental 
group. Statistical analysis of ABR peak ampli-
tudes revealed a difference at peak 1. Analysis 
of peak 1 showed a significant main effect 
of exposure [F (6, 48) = 2.826; p = 0.019]. 
We also found a significant effect of fre-
quency [F (3, 144) = 97.862; p < 0.001] and 
a significant effect of sex [F (1, 48) = 22.005; 
p < 0.001], as well as a sex × frequency inter-
action [F (3, 144) = 4.539; p = 0.005]. The 
sex effect was due to greater ABR amplitudes 
in female rats. There were no significant sex × 
exposure or frequency × exposure inter  actions 
on ABR peak 1 amplitudes. Tukey’s test 
revealed that ABR peak 1 amplitudes from 
the 1 mg/kg PCB group were significantly 
decreased compared with the 1.5 ppm MeHg 
group (p = 0.039) and the 4.5 ppm MeHg 
group (p = 0.036), but none of the groups 
differed significantly from the controls. We 
found no significant effects related to expo-
sure in the analysis of the amplitudes of ABR 
peaks 2, 3, or 4. Statistical analysis of ABR 
peak latencies revealed no significant effect of 
exposure at any of the four measured peaks.
Figure 4. Group mean ABR thresholds of control rats compared with exposed rats. Exposure to PCBs only (A), MeHg only (B), or PCBs + MeHg (C). Letters indicate 
a significant difference (p < 0.05) between controls and 3 mg/kg PCB (a), 1 mg/kg PCB (b), 4.5 ppm MeHg (c), 1 mg/kg PCB + 1.5 ppm MeHg (d), and 3 mg/kg PCB + 
4.5 ppm MeHg (e).
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Figure 5. Group mean ABR peak 1 amplitude across all frequencies. 
*Significant difference (p < 0.05).
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Discussion
The present study confirmed and extended 
the results obtained from previous studies 
conducted in our laboratory (Lasky et al. 
2002; Powers et al. 2006). Developmental 
PCB exposure resulted in permanent audi-
tory deficits in rats. PCB exposure was associ-
ated with attenuation of DPOAE amplitudes 
and elevation of DPOAE thresholds. PCB 
exposure was also associated with elevation of 
ABR thresholds. In contrast, developmental 
exposure to MeHg did not induce permanent 
auditory deficits. Unexpectedly, we found an 
apparent interaction such that the effects of 
PCB exposure were less pronounced in rats 
exposed to PCBs in combination with MeHg.
Rats maternally exposed to the Fox River 
PCB mixture showed reduced DPOAE ampli-
tudes, reflecting loss or impaired function of 
outer hair cells in the organ of Corti. As was 
observed previously (Powers et al. 2006), both 
the 1 and 3 mg/kg PCB dose groups appeared 
to have attenuated DPOAEs compared with 
controls, but the difference reached statisti-
cal significance only in the 3 mg/kg group. 
DPOAE thresholds were elevated, but unlike 
results from the earlier study, both dose 
groups showed significant differences from 
controls. DPOAE amplitudes and thresholds 
were unaffected by either of the MeHg doses.
Intriguingly, the effects of PCB exposure 
on DPOAEs appeared to be attenuated by 
coexposure to MeHg. DPOAE amplitudes 
from both combined exposure groups were 
similar to those of controls, although the 
high combined exposure group appeared to 
have slightly attenuated DPOAEs at 2, 3, and 
4 kHz. DPOAE thresholds were elevated in 
male rats from the 3 mg/kg PCB + 4.5 ppm 
MeHg group at 2 and 3 kHz; in females, 
both combined exposure groups had elevated 
thresholds at 2 kHz but showed no significant 
effects at other frequencies. Low-frequency 
hearing may be particularly sensitive to PCB 
exposure (Crofton and Rice 1999; Herr 
et al. 1996), and this may explain why low-
frequency deficits were not attenuated in the 
combined exposure groups. In general, the 
DPOAE threshold elevations in the combined 
exposure groups appeared similar to, but less 
pronounced than, the effects observed in rats 
exposed to PCBs alone.
Measurement of ABR thresholds yielded 
similar results. PCB-only groups had elevated 
ABR thresholds at 1.5, 3, and 12 kHz. The 
results were in slight contrast to our previ-
ous study, in which the 1 mg/kg PCB group 
did not differ significantly from controls. The 
4.5 ppm MeHg group had elevated ABR 
thresholds at 1.5 kHz, but no differences at 
any other frequency. Again, the effects of 
PCB exposure appeared to be attenuated by 
co-exposure to MeHg. Both combined expo-
sure groups had elevated ABR thresholds at 
1.5 kHz but did not differ from controls at 
other frequencies. Again, this may reflect par-
ticular sensitivity of low-frequency hearing to 
PCB exposure.
ABR peak amplitudes were relatively unaf-
fected by the exposure conditions. Although 
the amplitude of peak 1 was significantly 
lower in the 1 mg/kg PCB group compared 
with the two MeHg-only groups, none of the 
exposure groups differed significantly from 
controls. We are unsure of the significance 
of this finding because the data showed both 
a high degree of variability and large sex dif-
ferences. The ABR peak latencies were unaf-
fected by any of the exposure conditions.
Thresholds for DPOAEs and ABRs were 
elevated at some frequencies in the 1 mg/kg 
PCB group. Although the threshold eleva-
tions in this group were limited primarily to 
low frequencies, the effects contrast our pre-
vious study in which the 1 mg/kg PCB group 
did not differ from controls (Powers et al. 
2006). In the time between the two studies, 
our laboratory was relocated to a new testing 
room that was more isolated from outside 
noise, and we found that the DPOAE and 
ABR thresholds of control rats were lower 
than those of controls in the previous study. 
Subtle threshold elevations we observed in 
the 1 mg/kg PCB group may have been 
masked by greater background noise in the 
previous study.
The PCB-induced auditory deficits were 
consistent with earlier animal models of PCB 
exposure. Previous studies have reported ele-
vated low-frequency (1 kHz) hearing thresh-
olds for the acoustic startle response in rats 
developmentally exposed to Aroclor 1254 
(Goldey et al. 1995; Goldey and Crofton 
1998) or PCB-126 (Crofton and Rice 1999). 
The hearing deficit was later associated with 
a loss of outer hair cells in the upper mid-
dle and apical region of the organ of Corti 
(Crofton et al. 2000). Our laboratory helped 
confirm a cochlear site of action by demon-
strating DPOAE deficits at low frequencies 
in rats developmentally exposed to Aroclor 
1254 (Lasky et al. 2002). Developmental 
exposure to the Fox River PCB mixture 
caused similar deficits that extended across 
a broader range of frequencies (Powers et al. 
2006). The observation that PCB exposure 
resulted in ABR threshold elevations is also 
consistent with an effect at the level of the 
cochlea. However, a recent study of rats with 
early exposure to PCB-95 showed an altera-
tion in the tonotopic mapping of the primary 
auditory cortex, which occurred in rats that 
did not appear to have peripheral hearing 
deficits (Kenet et al. 2007).
The various PCB mixtures and individ-
ual congeners may be exerting their effects 
through different mechanisms. PCB-induced 
reduction of circulating thyroid hormone 
levels may have a significant role in hearing 
loss. Hypothyroidism in pregnant women has 
long been known to cause hearing deficits in 
children (Sher et al. 1998). Animal models 
have also shown that maternal hypothyroid-
ism causes structural and functional deficits in 
the auditory system (Uziel et al. 1980, 1981), 
including impaired DPOAEs (Knipper et al. 
2000). Furthermore, thyroxine replacement 
in the offspring of rats exposed to Aroclor 
1254 partially ameliorated hypothyroxinemia 
and hearing loss (Goldey and Crofton 1998).
However, PCBs may also induce auditory 
deficits via their effects on RyR activity. PCBs 
can act on the RyR by stabilizing a high-af-
finity binding conformation, which results 
in increased intracellular calcium concentra-
tions (Wong et al. 1997). Alterations of intra-
cellular calcium concentrations could have 
detrimental effects on cells in the central audi-
tory pathway. Although speculative, both thy-
roid-hormone–mediated and RyR-mediated 
mechanisms may be involved in PCB-induced 
hearing loss, and individual PCB congeners 
may differ in the extent of involvement. For 
example, PCB-95 is a potent activator of the 
RyR but has only modest effects on thyroid 
hormone concentrations. This may explain 
the observations by Kenet et al. (2007). The 
altered tonotopic mapping of the auditory 
cortex may have resulted from disruption of 
RyR signaling in cortical neurons, whereas 
cochlear function remained normal because of 
a lack of effect on thyroid hormone.
We did not observe hearing deficits in 
rats developmentally exposed to MeHg, 
with the exception of elevated ABR thresh-
olds at 1.5 kHz. Previous rodent models 
have reported MeHg-induced hearing defi-
cits, but the studies did not involve devel-
opmental exposure, and deficits were not 
permanent (Chuu et al. 2001; Huang et al 
2008). Primate models have also shown 
MeHg-induced hearing impairment, but this 
followed lengthy exposure durations that con-
tinued throughout life (Rice 1998; Rice and 
Gilbert 1992). MeHg may induce only tran-
sient hearing deficits from which there can be 
functional recovery.
A surprising result of the present study 
was that coexposure to MeHg appeared to 
attenuate PCB-induced hearing deficits. A 
similar attenuation of PCB-induced effects 
was observed when littermates of the animals 
tested in the present study were tested for 
cognitive function (Sable at al. 2009). Rats 
were trained on a differential reinforcement 
of low rates operant task. PCB-exposed 
groups had a lower ratio of reinforced to non-
reinforced responses than controls. MeHg-
exposed rats were not impaired on this task. 
However, groups exposed to combined doses 
of PCBs and MeHg did not show the defi-
cits observed in rats exposed to PCBs alone. Contaminant exposure and auditory function
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Previous studies in our laboratory showed 
that coexposure to PCBs and MeHg exacer-
bated PCB-induced motor impairments on 
a rotating rod task (Roegge et al. 2004) but 
did not exacerbate PCB-induced impairments 
on a spatial alternation task (Widholm et al. 
2004). However, those studies used a different 
PCB mixture and a different dose of MeHg. 
Interactive effects of coexposure to PCBs 
and MeHg have also been observed in vitro 
(Bemis and Seegal 2000). In rat brain tissue, 
exposure to either PCBs or MeHg caused 
an elevation of intracellular calcium concen-
trations. A statistical interaction revealed a 
difference between the effects of coexposure 
and the effects of exposure to either of the 
two chemicals individually, with co  exposure 
having greater effects. Additionally, high-
  combination doses or longer exposure dura-
tions to low-combination doses reduced 
calcium concentrations compared with 
elevations observed after exposure to MeHg 
only. It is evident that PCBs and MeHg can 
interact in complex ways to cause functional 
changes, but the nature of this interaction 
remains unresolved.
Although the doses used in this study were 
significantly higher than would typically be 
encountered in children from environmental 
exposure, basic principles of allometric scaling 
dictate that rodents must receive much higher 
doses than humans in order to achieve com-
parable body burdens. Although it is difficult 
to make cross-species comparisons of PCB 
dose, we estimate that body burdens in the 
present study are similar to body burdens that 
have been documented in more highly PCB-
exposed human populations in other parts 
of the world, such as populations living near 
former PCB manufacturing sites in eastern 
Europe (Cerna et al. 2008).
Both PCB and MeHg exposure have been 
associated with hearing deficits in human epi-
demiologic studies, but the data are very lim-
ited because auditory function has not been 
a primary focus of these studies (Wigle et al. 
2008). Higher exposures have been associated 
with elevated hearing thresholds, using tradi-
tional audiometric methods, but the effects 
were observed only at specific frequencies 
and only unilaterally. Our studies have indi-
cated that DPOAEs and ABRs are sensitive 
measures of PCB-induced auditory impair-
ments. It would be advisable that future epi-
demiologic studies use these methods because 
they can easily measure auditory function in 
human adults and children and they may be 
particularly sensitive to PCB-induced effects.
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